Articles On Immutep (ASX:IMM)

The Adairs Ltd (ASX: ADH) share price suffered a big sell-off last week – it fell around 15% on Friday. It’s down 28% from 22 May 2023 and it has dropped 45% from 1 February 2023. The ASX All Ordinaries Index (ASX: XAO) share has been...

If you have room for some new portfolio additions in June, then it could be worth considering the three ASX growth shares listed below. Here’s what you need to know about these buy-rated shares: Aristocrat Leisure Limited (ASX: ALL) The...

Several new health-focused funds joined the biotech’s register including Platinum.

If you’re searching for a passive income boost, then you may want to check out the ASX dividend stocks listed below. Analysts have named these dividend stocks as buys and tipped them to provide very large yields in the near term. Hereâ€...

ASX retail shares are falling amid news today of a 5.75% hike to the minimum wage and concern among investors about the rising cost of living now affecting retail sales in 2023. Earlier today the Fair Work Commission announced a 5.75% bum...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on track to end the week on a positive note. At the time of writing, the benchmark index is up 0.25% to 7,129.3 points. Four ASX shares that have failed to follow the market high...

The Bubs Australia Ltd (ASX: BUB) share price is falling on more disappointing sales data from China and amid a move that could see four board members canned. Bubs founder and former CEO Kristy Carr is leading a group of shareholders calli...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

The ASX 200 fell 1.37%, and the bad news kept piling up all day Inflation data knee-capped the market mid-morning, because rate hikes are on the way Two Small Caps hit triple-figure home runs today, which is kinda amazing   Welp… that was...

The immunotherapy biotech had brokers Bell Potter, Jefferies and Wilsons in its corner on Wednesday.

The S&P/ASX 300 (ASX: XKO) has climbed 0.78% in the last two days, but this ASX 300 lithium share is far outperforming the index. The Leo Lithium Ltd (ASX: LLL) share price is up 29% this trading week and is now at 93.2 cents. In toda...

Immutep (ASX:IMM) has announced it has entered into an agreement under which Charles River will conduct a GLP toxicology study for IMP761.

ASX lithium share Leo Lithium Ltd (ASX: LLL) is soaring higher today, up 13.8% in early trade. Shares in the S&P/ASX 300 Index (ASX: XKO) lithium stock closed Friday trading for 72.5 cents. In early trade on Monday, shares are swapping...

ShareCafeThe Week that Was: May 22-26, 2023 We at ShareCafe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. To make it easier to do so, her...

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think th...

ASX health stocks have fallen in the past five days in line with broader markets Volpara Health Technologies reports strong FY23 results, above Morgan’s expectations Pharmaxis reports positive trial results in potential breakthrough treatm...

The S&P/ASX 200 Index (ASX: XJO) tumbled on Thursday, falling 1.05% to close at 7,138.2 points. The market’s suffering came amid continued concerns of the United States’ rapidly approaching debt ceiling, as my Fool colleague Bernd...

The market is continuing its downward trend for today, with the ASX200 around 0.8 per cent lower in early afternoon trade. Diversified miner, Sandfire Resources (SFR), has produced first copper concentrate at its Motheo copper mine in Bo...

The S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and dropped into the red. At the time of writing, the benchmark index is down 0.85% to 7,151.5. Four ASX shares that are not letting that stop them from rising today...

This content is created by Smallcaps Authors. [Author : Imelda Cotton] Biotechnology company Immutep (ASX: IMM) has safely dosed the first patient at a European clinical site for its integrated Phase II/III AIPAC-003 trial to treat metast...

Immutep (IMM) enrols and doses its first patient at its European clinical site for its integrated Phase II/III AIPAC-003 trial The trial aims to evaluate the effectiveness of Immutep’s drug candidate, eftilagimod alpha (efti), in combi...

The Webjet Limited (ASX: WEB) share price has been on form this week. So much so, the online travel agent’s shares hit a new 52-week high on Wednesday. This means the company’s shares are now up almost 23% since the start of the year....

The ASX is expected to fall today on the back of overnight losses across other global markets, namely Europe and the US. Here are some ASX-listed companies to watch out for on Thursday: The first patient in Immutep’s (IMM) AIPAC-003 p...

ASX lithium share Delta Lithium Ltd (ASX: DLI) may not be a household name, but it appears it is attracting interest from billionaire investors. Delta Lithium shares have soared nearly 37% year to date and 44% in the last month. So what...

The average Australian’s superannuation balance leaves much to be desired for one seeking a comfortable retirement. Fortunately, there’s a solution. Let’s dive into what anyone hoping to enter retirement without a large super balance c...

On Wednesday, the S&P/ASX 200 Index (ASX: XJO) was out of form and dropped into the red. The benchmark fell 0.6% to 7,213.8 points. Will the market be able to bounce back from this on Thursday? Here are five things to watch: ASX 200...

Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week   Earlier this week, Pfizer surprised the market by say...

The S&P/ASX 200 Index (ASX: XJO) struggled in Wednesday’s session, falling 0.63% to close at 7,213.8 points. That was despite a strong performance from the S&P/ASX 200 Energy Index (ASX: XEJ), which lifted 0.7% on the back of ri...

The S&P/ASX 200 Index (ASX: XJO) has dropped into the red on Wednesday. In afternoon trade, the benchmark index is down 0.5% to 7,221.4 points. Four ASX shares that are not letting that hold them back are listed below. Here’s why th...

Patry receives positive toxicology reports on PAT-DX1 Immutep says triple combination trial of Efti shows it is well tolerated Clarity Pharma is now advancing to cohort 2   Patrys receives positive report Therapeutic antibody development...

ShareCafeUBS and Credit Suisse nearing completion of merger: ASX 0.46% lower at noon by Peter Milios   At noon, the S&P/ASX 200 is 0.46 per cent lower at 7,226.50. The SPI futures are pointing to a fall of 28 points. The decline coincid...

24 May 2023 - A snapshot of the stocks on the move featuring Leo Lithium (ASX:LLL), Empire Energy (ASX:EEG), Immutep (ASX:IMM) and Cauldron Energy (ASX:CXU).

ShareCafeStocks of the Hour: LLL, EEG, IMM, CXU                    Leo Lithium (ASX:LLL) has announced that further drilling at their Goulamina Lithium Project has delivered thick, high grade mineralisation. MD Simon Hay commented, “W...

ShareCafeImmutep’s Positive FDA Talks and Strong Survival Data Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the significance of recent announcements on the back of a recent surge in trading volume. Paul Sanger:...

ASX health stocks rise in the past five days in line with broader markets Immutep  surges 46% after positive Phase 2 results into lung cancer Avita Medical falls 28% in past five days despite reporting “solid Q1 FY23” results Healthcare a...

Immutep gets US FDA clearance to start Phase 1 study Noxopharm says its Sofra platform is effective against inflammatory skin disease Epsilon Healthcare announced a new CEO   US FDA approves Imugene’s Phase 1 Immuno-oncology biotech Imug...

ShareCafeASX closes 0.52% higher as high iron ore price boosts bellwethers by Peter Milios   At the closing bell, the S&P/ASX 200 was 0.52 per cent higher at 7,236.80. Nufarm (ASX:NUF) rallied 14.2 per cent to $6.05 after announcing a 7...

S&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining regulator issues a mining permit for Terramin’s Tala Hamza zinc-lead project Retail component of Next DC’s entitlement offer opens and is expec...

The S&P/ASX 200 Health Care (ASX: XHJ) index has slid 0.55% in the last two days, but this ASX healthcare share has defied the trend. The Immutep Ltd (ASX: IMM) share price has rocketed 51% from 23.5 cents at market close on 16 May to...

ShareCafeASX up 0.59% after surprise jobs data by Peter Milios   According to the Australian Bureau of Statistics, the economy experienced a loss of 4,300 jobs in the previous month, which was contrary to economists’ predictions of gaining...

ShareCafeStocks of the Hour: LRS, EMH, G88, IMM                    Latin Resources (ASX:LRS) announced that drilling confirms that their Colina deposit has lithium pegmatites extending over 2KM. VP of Operations, Tony Greenaway commen...

18 May 2023 - A snapshot of the stocks on the move featuring Latin Resources (ASX:LRS), European Metals (ASX:EMH), Golden Mile Resources (ASX:G88) and Immutep (ASX:IMM).

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Immutep (ASX:IMM) has reported positive results from a clinical trial of its LAG-3 immunotherapy in combination with MSD's PBS-listed anti-PD-1 therapy KEYTRUDA (pembrolizumab).

Rhythm Biosciences surged 70pc this morning after being granted the UK CA Mark for ColoSTAT Anteris Tech was issued another patent in the US Immutep reported positive Phase 2 results   It’s a big day for medical diagnostics company Rhythm...

ShareCafeASX closes 0.45% lower as healthcare, tech and consumer staples suffer by Peter Milios   On Tuesday, at the closing bell, the S&P/ASX 200 was 0.45 per cent lower at 7,234.70, as the healthcare, tech, and consumer staples sector...

ShareCafeRBA indicates more hikes may be necessary: ASX 0.15% lower at noon by Peter Milios   The Reserve Bank’s minutes for May indicate that the central bank is committed to reducing inflation. The Board expressed its determination to tak...

16 May 2023 - A snapshot of the stocks on the move featuring Spenda (ASX:SPX), Cettire (ASX:CTT) and Immutep (ASX:IMM).

Immutep (IMM) gains the green light from the US FDA to move ahead with its late-stage clinical plans to treat first-line, non-small cell lung cancer (NSCLC) The trial will assess the efficacy of eftilagimod alpha (Efti) in combination wi...

ShareCafeStocks of the Hour: SPX, CTT, IMM                    Building upon a 20-year commercial foundation, Capricorn Society has selected Spenda (ASX:SPX) as its preferred supplier to deliver the first phase of its Digital Service D...